Session Datesort descending
Cristina Valencia Sanchez, M.D., Ph.D. | Neurological Immune-related Complications of Immune Checkpoint Inhibitors 01/13/2022 - 8:00am to 9:00am
Gregory A. Poland, M.D., FIDSA, MACP, FRCP (hon) | Year Three of COVID-19: Harsh Truths, Realities, and Glimmers of Hope 01/20/2022 - 8:00am to 9:00am
Lola Fashoyin-Aje, M.D., MPH | Inclusive Cancer Clinical Research: A Regulatory Perspective 01/25/2022 - 12:00pm to 1:00pm
Aaron S. Mansfield, M.D. | Targeting Mesothelioma 01/27/2022 - 8:00am to 9:00am
Michael B. Atkins, M.D. | Treatment of Patients with Metastatic BRAF Mutant Melanoma: To Sequence or Combine 02/03/2022 - 8:00am to 9:00am
Tanios Bekaii-Saab, M.D., FACP | Successes and Failures in Drug Development in Pancreatic Cancer 02/10/2022 - 8:00am to 9:00am
Carlo C. Maley, Ph.D., What is a Cancer Hallmark and are we Missing any? 02/17/2022 - 8:00am to 9:00am
James L. Kirkland, M.D., Ph.D. | Cellular Senescence, Senolytics, Cancer, and Aging 02/24/2022 - 8:00am to 9:00am
Safia K. Ahmed, M.D. | Local Therapy for Sarcoma: Current Concepts and Opportunities for Improvement 03/03/2022 - 8:00am to 9:00am
Steven E. Schild, M.D. | Local Radiotherapy in SCLC (Small Cell Lung Cancer) 03/10/2022 - 8:00am to 9:00am

Pages